表紙:遺伝毒性検査の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測
市場調査レポート
商品コード
1342770

遺伝毒性検査の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測

Global Genetic Toxicology Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日: | 発行: Value Market Research | ページ情報: 英文 174 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
遺伝毒性検査の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝毒性検査市場の世界需要は、2022年の43億9,000万米ドルから2030年には151億9,000万米ドル近くの市場規模に達すると推定され、調査期間2022~2030年のCAGRは14.82%です。

遺伝毒性試験は、多様な生物学的、物理的、化学的物質が生物に及ぼす遺伝的影響を調査します。遺伝毒性学は、DNA損傷の有害な結果に関する研究です。これらの検査は染色体の損傷や遺伝子の突然変異を調べるために行われます。毒性学的研究は、医薬品の不純物、農薬、化粧品用化学物質、医薬品、工業用化学物質に対して行われます。これらの試験は、新しいワクチンや医薬品の開発に役立っています。また、これらの検査では、in vitroのアプローチを用いて、オーダーメイドの治療や医薬品開発に焦点を当てています。

市場力学:

ヘルスケア、食品、化粧品における遺伝毒性検査のニーズの高まりが市場を強化しています。医薬品開発と承認のための研究開発イニシアチブへの投資が行われており、これが遺伝毒性検査の需要を高め、市場を後押ししています。遺伝毒性検査は、感染症、治療、免疫学的反応に対する人体への薬物影響を確実に検出するため、市場拡大が見込まれます。遺伝毒性検査市場は、ヒトの複雑なエンドポイントを研究するためのより効果的で実績のあるin vitroモデルの必要性、検査方法に関する厳しい規制、研究における動物の継続的使用など、いくつかの要因によって制限される可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、遺伝毒性検査の世界市場における各セグメントを包括的に評価することもできます。遺伝毒性検査産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析:

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおける遺伝毒性検査市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 遺伝毒性検査-産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 遺伝毒性検査の世界市場分析:タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • インビトロ
  • インビボ

第7章 遺伝毒性検査の世界市場分析:製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 試薬・消耗品
  • アッセイ
  • サービス

第8章 遺伝毒性検査の世界市場売上分析:用途別

  • 概要:用途別
  • 実績データと予測データ
  • 分析:用途別
  • 医薬品・バイオテクノロジー
  • 食品産業
  • 化粧品産業
  • その他

第9章 遺伝毒性検査の世界市場売上分析:地域別

  • 地域別展望販売分析
  • イントロダクション売上分析
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 遺伝毒性検査企業の競合情勢

  • 遺伝毒性検査市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第11章 企業プロファイル

  • 上位10社のシェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International
  • Laboratory Corp of America Holdings
  • Eurofins Scientific
  • Jubilant Life Sciences Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • In Vitro Market Sales by Geography (USD MN)
  • In Vivo Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Reagents & Consumables Market Sales by Geography (USD MN)
  • Assays Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Pharmaceutical & Biotechnology Market Sales by Geography (USD MN)
  • Food Industry Market Sales by Geography (USD MN)
  • Cosmetics Industry Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Genetic Toxicology Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genetic Toxicology Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Genetic Toxicology Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • In Vitro Market Sales by Geography (USD MN)
  • In Vivo Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Reagents & Consumables Market Sales by Geography (USD MN)
  • Assays Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Pharmaceutical & Biotechnology Market Sales by Geography (USD MN)
  • Food Industry Market Sales by Geography (USD MN)
  • Cosmetics Industry Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219924

The global demand for Genetic Toxicology Testing Market is presumed to reach the market size of nearly USD 15.19 BN by 2030 from USD 4.39 BN in 2022 with a CAGR of 14.82% under the study period 2022 - 2030.

Genetic Toxicology testing investigates the genetic effects of diverse biological, physical, and chemical substances on living organisms. Genetic toxicology is the study of the harmful consequences of DNA damage. These tests are performed to find out about chromosomal damage and genetic mutation. Toxicology studies are performed on pharmaceutical impurities, agrochemicals, cosmetic chemicals, pharmaceutical medicines, and industrial chemicals. These tests aid in the development of new vaccines and medications. These tests also used in vitro approaches to focus on customized treatment and drug development.

MARKET DYNAMICS:

The rising need for genetic toxicology testing in healthcare, food, and cosmetics enhances the market. There have been investments in research and development initiatives for medication development and approval, which has increased the demand for genetic toxicology testing, thus boosting the market. Genetic toxicology testing may see market expansion for reliable detection of medication effects on humans for infection, treatments, and immunological responses. The market for genetic toxicology testing might be restricted by a few factors, such as the need for more effective and proven in vitro models for studying complex endpoints on humans, strict regulations on testing methods, and the continued use of animals in research.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of genetic toxicology testing. The growth and trends of genetic toxicology testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the genetic toxicology testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • In Vitro
  • In Vivo

By Product

  • Reagents & Consumables
  • Assays
  • Services

By Application

  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Genetic Toxicology Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the genetic toxicology testing market include Thermo Fisher Scientific Inc., Charles River Laboratories International, Laboratory Corp of America Holdings, Eurofins Scientific, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Creative Bioarray, MB Research Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GENETIC TOXICOLOGY TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 In Vitro Historic and Forecast Sales by Regions
  • 6.5 In Vivo Historic and Forecast Sales by Regions

7 . GLOBAL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Reagents & Consumables Historic and Forecast Sales by Regions
  • 7.5 Assays Historic and Forecast Sales by Regions
  • 7.6 Services Historic and Forecast Sales by Regions

8 . GLOBAL GENETIC TOXICOLOGY TESTING MARKET SALES ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Pharmaceutical & Biotechnology Historic and Forecast Sales by Regions
  • 8.5 Food Industry Historic and Forecast Sales by Regions
  • 8.6 Cosmetics Industry Historic and Forecast Sales by Regions
  • 8.7 Other Historic and Forecast Sales by Regions

9 . GLOBAL GENETIC TOXICOLOGY TESTING MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE GENETIC TOXICOLOGY TESTING COMPANIES

  • 10.1. Genetic Toxicology Testing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF GENETIC TOXICOLOGY TESTING INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Charles River Laboratories International
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Laboratory Corp of America Holdings
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Eurofins Scientific
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Jubilant Life Sciences Limited
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Syngene International Limited
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Gentronix Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Inotiv Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Creative Bioarray
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. MB Research Laboratories
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies